Showing 3401-3410 of 23180 results for "".
Recognizing When to Escalate Therapy in Atopic Dermatitis Care
https://reachmd.com/programs/dermconsult/escalating-therapy-atopic-dermatitis/49019/Identifying when to escalate therapy in atopic dermatitis can be challenging when standard scoring tools don't capture the full patient burden. However, combining clinical insights with patient-reported outcomes like itch, pain, and sleep disruption can help guide timely systemic treatment decisionsFace Value with Modern Aesthetics: 2025 EYECODE Protocol Update Part 2
https://reachmd.com/series/face-value/face-value-with-modern-aesthetics-2025-eyecode-protocol-update-part-2/54387/This week we are joined by Modern Aesthetics medical editor Dr. Saami Khalifian, board member Dr. Sheila Barbarino, and Dr. John Fezza to discuss the 2025 EYECODE Protocol Update. This is part 2 of a 3 part series.The Future of Customized Treatments Within the Atopic Dermatitis Pipeline
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/the-future-of-customized-treatments-within-the-atopic-dermatitis-pipeline/37165/Practical Dermatology Editorial Board member Peter Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine, discusses the potential impact of new developments in atopic dermatitis research.Next-Generation Technology Built on a Trusted Legacy
https://reachmd.com/programs/modern-aesthetics/next-generation-technology-built-on-a-trusted-legacy/49014/Advances in COVID-19 Protection: A Look at the mRNA-1283 Vaccine
https://reachmd.com/programs/clinicians-roundtable/advances-in-covid-19-protection-a-look-at-the-mrna-1283-vaccine/36420/The mRNA-1283 COVID-19 vaccine is a next-generation approach to immunization, focusing the immune response on key components of the SARS-CoV-2 spike protein. By targeting both the receptor-binding and N-terminal domains, this vaccine aims to enhance the potency and durability of neutralizing antibodManaging Statin Intolerance: Practical Approaches and Emerging Non-Statin Options
https://reachmd.com/programs/heart-matters/managing-statin-intolerance-practical-approaches-and-emerging-non-statin-options/37858/Statin intolerance, though uncommon, presents a challenge for patients who experience persistent side effects despite adjustments in dosing or switching statins. Dr. Matthew Sorrentino reviews evidence-baesd alternatives, shares insights on practical use in clinical care, and highlights the latest aAdvances in Pediatric Eczema Care: Emerging Biologics, JAK Inhibitors, and Beyond
https://reachmd.com/programs/dermconsult/advances-in-pediatric-eczema-care-emerging-biologics-jak-inhibitors-and-beyond/35500/Between four FDA-approved biologics, two oral JAK inhibitors, and an exciting pipeline that features novel therapies and extended dosing innovations, the treatment of pediatric eczema is rapidly evolving. Catch up on the latest updates and where the landscape is headed with Dr. Peter Lio, Clinical AResearch Highlights Disparities in AD Care
https://reachmd.com/programs/practical-dermatology/research-highlights-disparities-in-ad-care/36472/In this episode of DermwireTV, research on socioeconomic disparities in atopic dermatitis care; new information on guselkumab for scalp psoriasis in diverse skin tones; the impact of air quality on dermatitis; and a C-Suite Chat with Anastasia Georgievskaya, founder of Haut.AI.Navigating Myasthenia Gravis in Adolescents and Young Adults
https://reachmd.com/programs/neurofrontiers/navigating-myasthenia-gravis-in-adolescents-and-young-adults/30067/Explore the challenges of diagnosing and treating myasthenia gravis in adolescents and young adults.Dr. Dawn K. Smith HIV Prevention Clinical Fellowship Announced at CROI 2024
https://reachmd.com/programs/clinicians-roundtable/dr-dawn-k-smith-hiv-prevention-clinical-fellowship-announced-at-croi-2024/18002/The Dr. Dawn K. Smith HIV Prevention Clinical Fellowship was announced at CROI 2024. Read more for details.